Biogen Idec Financial Statements
Biogen Idec Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Biogen Idec Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 3,171.6 | 2,683.1 | 2,422.5 |
| Gross Profit ($ mil.) | 2,836.4 | 2,408.7 | 2,048.9 |
| Operating Income ($ mil.) | 779.8 | 440.0 | 236.0 |
| Total Net Income ($ mil.) | 638.2 | 217.5 | 160.7 |
| Diluted EPS (Net Income) | 1.99 | 0.63 | 0.47 |
Biogen Idec Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 942.2 | 893.3 | 789.2 |
| Gross Profit ($ mil.) | 841.3 | 805.7 | 707.6 |
| Operating Income ($ mil.) | 246.0 | 262.4 | 129.2 |
| Total Net Income ($ mil.) | 163.1 | 201.1 | 119.4 |
| Diluted EPS (Net Income) | 0.54 | 0.65 | 0.42 |
Biogen Idec Stock Quote & Chart
07/03/08 12:00:02 EST •
NASDAQ •
58.20
•
 -0.1600
•
-0.2742 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Biogen Idec Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 5.03 | 3.77 | 1.54 |
| Price/Earnings Ratio | 26.77 | 15.99 | 15.14 |
| Price/Book Ratio | 3.09 | 2.70 | 1.46 |
| Price/Cash Flow Ratio | 15.19 | 11.60 | 9.41 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Biogen Idec Financial Ratios
Biogen Idec Competitive Intelligence
| Bayer HealthCare Pharmaceuticals | Bristol-Myers Squibb | Merck Serono | |
|---|---|---|---|
| Annual Sales ($ mil.) | 1,258.9 | 19,348.0 | 2,586.4 |
| Employees | 2,000 | 42,000 | 4,826 |
| Market Cap ($ mil.) | -- | 38,848.3 | -- |
Competitive Landscape
